GeneXpert Xpress from Cepheid
Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics — and the company has never looked back.
The GeneXpert System has been heralded as game-changing by healthcare leaders across the globe, enabling institutions of any size, from small medical clinics to high-volume reference
laboratories and hospitals, to access the speed and accuracy of molecular diagnostics.
Cepheid’s growing Xpert test menu spans multiple clinical applications including healthcare-associated infections, sexual health, critical infectious disease, virology and oncology.
www.cepheid.com
Other News
Featured Supplier
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...
Upcoming Events
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
